Preterm infants fed Prolacta’s 100% human milk-based fortifiers achieved catch-up growth by age 2 with appropriate neurodevelopmental outcomes, study says
Type: Press Releases
Topic(s): Growth Long-Term outcomes
Head-to-head subgroup analysis of human milk–based fortifiers finds significant improvements in health and brain growth measure for preemies fed mother’s milk plus Prolacta’s fortifiers
Type: Press Releases
Topic(s): Growth Neurodevelopmental Outcomes Total Parenteral Nutrition (TPN) Use
The story of Kallie, as told by her mom, Ebonie
Type: Parent Stories
Topic(s): 22-27 weeks (extremely premature)
Donor Sarah
Type: Donor Stories
Topic(s): Tiny Treasures
The story of Evelyne, as told by her mom, Tiffany
Type: Parent Stories
Topic(s): 28-32 weeks (very premature)
Prolacta Bioscience reassures hospitals of the safety of its human milk-based nutritional products during the coronavirus pandemic
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Pasteurization Quality & Safety
Providing safe nutritional products during the Coronavirus outbreak
Type: Blog
Topic(s): Quality & Safety
Donor Ashlee
Type: Donor Stories
Topic(s): Tiny Treasures
Banner - University Medicine Tucson Adopts Prolacta’s Exclusive Human Milk Diet
Type: Prolacta in the News
Topic(s): Hospital Experience
